Literature DB >> 23483432

Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions.

Suhail B Noolkar1, Namdeo R Jadhav, Santosh A Bhende, Suresh G Killedar.   

Abstract

The effect of ternary solid dispersions of poor water-soluble NSAID meloxicam with moringa coagulant (obtained by salt extraction of moringa seeds) and polyvinylpyrrolidone on the in vitro dissolution properties has been investigated. Binary (meloxicam-moringa and meloxicam-polyvinylpyrrolidone (PVP)) and ternary (meloxicam-moringa-PVP) systems were prepared by physical kneading and ball milling and characterized by Fourier transform infrared spectroscopy, differential scanning calorimetry, and X-ray diffractometry. The in vitro dissolution behavior of meloxicam from the different products was evaluated by means of United States Pharmacopeia type II dissolution apparatus. The results of solid-state studies indicated the presence of strong interactions between meloxicam, moringa, and PVP which were of totally amorphous nature. All ternary combinations were significantly more effective than the corresponding binary systems in improving the dissolution rate of meloxicam. The best performance in this respect was given by the ternary combination employing meloxicam-moringa-PVP ratio of [1:(3:1)] prepared by ball milling, with about six times increase in percent dissolution rate, whereas meloxicam-moringa (1:3) and meloxicam-PVP (1:4) prepared by ball milling improved dissolution of meloxicam by almost 3- and 2.5-folds, respectively. The achieved excellent dissolution enhancement of meloxicam in the ternary systems was attributed to the combined effects of impartation of hydrophilic characteristic by PVP, as well as to the synergistic interaction between moringa and PVP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23483432      PMCID: PMC3665984          DOI: 10.1208/s12249-013-9941-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

1.  Moringa coagulant as a stabilizer for amorphous solids: Part I.

Authors:  Santosh Bhende; Namdeo Jadhav
Journal:  AAPS PharmSciTech       Date:  2012-02-23       Impact factor: 3.246

2.  Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique.

Authors:  J Y Jung; S D Yoo; S H Lee; K H Kim; D S Yoon; K H Lee
Journal:  Int J Pharm       Date:  1999-10-05       Impact factor: 5.875

Review 3.  Pharmaceutical applications of solid dispersion systems.

Authors:  W L Chiou; S Riegelman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

4.  Determination of tablet strength by the diametral-compression test.

Authors:  J T Fell; J M Newton
Journal:  J Pharm Sci       Date:  1970-05       Impact factor: 3.534

5.  Isolation and characterization of a flocculating protein from Moringa oleifera Lam.

Authors:  U Gassenschmidt; K D Jany; B Tauscher; H Niebergall
Journal:  Biochim Biophys Acta       Date:  1995-04-13

6.  Physical properties of solid dispersion of a nonsteroidal anti-inflammatory drug (M-5011) with Eudragit E.

Authors:  E Horisawa; K Danjo; M Haruna
Journal:  Drug Dev Ind Pharm       Date:  2000-12       Impact factor: 3.225

7.  Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri
Journal:  Int J Pharm       Date:  2003-07-24       Impact factor: 5.875

8.  Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier.

Authors:  Noriyuki Hirasawa; Sayoko Ishise; Hitomi Miyata; Kazumi Danjo
Journal:  Drug Dev Ind Pharm       Date:  2003-03       Impact factor: 3.225

9.  Application of nilvadipine solid dispersion to tablet formulation and manufacturing using crospovidone and methylcellulose as dispersion carriers.

Authors:  Noriyuki Hirasawa; Sayoko Ishise; Hitomi Miyata; Kazumi Danjo
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-02       Impact factor: 1.645

10.  Enteric solid dispersion of ciclosporin A (CiA) having potential to deliver CiA into lymphatics.

Authors:  K Takada; M Oh-hashi; Y Furuya; H Yoshikawa; S Muranishi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1989-02       Impact factor: 1.645

View more
  5 in total

Review 1.  In pursuit of functional electrospun materials for clinical applications in humans.

Authors:  Ryan J Stoddard; Arielle L Steger; Anna K Blakney; Kim A Woodrow
Journal:  Ther Deliv       Date:  2016-06-02

2.  Effervescence Assisted Fusion Technique to Enhance the Solubility of Drugs.

Authors:  Mohd Aftab Alam; Fahad I Al-Jenoobi; Abdullah M Al-Mohizea; Raisuddin Ali
Journal:  AAPS PharmSciTech       Date:  2015-08-12       Impact factor: 3.246

3.  Comparison between the dissolution profiles of nine meloxicam tablet brands commercially available in Buenos Aires, Argentina.

Authors:  Laura D Simionato; Luciana Petrone; Mariela Baldut; Silvina L Bonafede; Adriana Inés Segall
Journal:  Saudi Pharm J       Date:  2018-02-09       Impact factor: 4.330

4.  Formulation and clinical investigation of optimized vinpocetine lyoplant-tabs: new strategy in development of buccal solid dosage form.

Authors:  Tarek A Ahmed
Journal:  Drug Des Devel Ther       Date:  2018-12-28       Impact factor: 4.162

5.  Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity.

Authors:  Tarek A Ahmed
Journal:  BMC Pharmacol Toxicol       Date:  2020-02-21       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.